Literature DB >> 11078760

Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors.

M L Slattery1, K Curtin, K Anderson, K N Ma, L Ballard, S Edwards, D Schaffer, J Potter, M Leppert, W S Samowitz.   

Abstract

BACKGROUND: Microsatellite instability (MSI) has been reported to occur in approximately 10%-15% of colon tumors. MSI is characterized by the presence of mutations in tandemly repeated DNA sequences known as microsatellites. Some individuals with unstable tumors have inherited mutations in mismatch repair genes, but MSI is also observed in sporadic colon cancer. It is unknown whether lifestyle factors associated with colon cancer, such as physical activity, body size, cigarette smoking, or use of aspirin and/or nonsteroidal anti-inflammatory drugs, contribute to MSI in sporadic tumors.
METHODS: Data from a population-based, case-control study of colon cancer were used. Case subjects were between 30 and 79 years of age at the time of diagnosis and included both men and women. Questionnaire data were used to obtain information on lifestyle factors. Tumor MSI was determined with the use of a panel of 10 tetranucleotide repeats and two mononucleotide repeats. A total of 1510 case subjects had valid questionnaire data and tumor DNA from which we were able to obtain MSI status. Questionnaire data were compared with lifestyle factors reported by 2410 population-based control subjects. All statistical tests were two-sided.
RESULTS: MSI-positive (MSI(+)) tumors were most common in older people and women and in the proximal colon. Patients with MSI(+) tumors were more likely to smoke 20 or more cigarettes a day than case subjects with MSI-negative (MSI(-)) tumors (odds ratio for being a smoker = 1.6 [95% confidence interval = 1.0-2.5] for men and 2.2 [95% confidence interval = 1.4-3.5] for women). The association between MSI(+) tumors and cigarette smoking was strongest among case subjects who started to smoke at a young age, smoked for 35 or more years, and were either current smokers or had stopped fewer than 15 years before diagnosis. A statistically significant linear trend of increased risk of MSI(+) tumors was observed with increasing amount smoked (P<.01).
CONCLUSIONS: This study suggests that smoking cigarettes statistically significantly contributes to MSI in colon tumors. We estimate that approximately 21% of MSI in colon tumors may be attributable to cigarette smoking.

Entities:  

Mesh:

Year:  2000        PMID: 11078760     DOI: 10.1093/jnci/92.22.1831

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  141 in total

1.  Body mass, tobacco smoking, alcohol drinking and risk of cancer of the small intestine--a pooled analysis of over 500,000 subjects in the Asia Cohort Consortium.

Authors:  P Boffetta; W D Hazelton; Y Chen; R Sinha; M Inoue; Y T Gao; W P Koh; X O Shu; E J Grant; I Tsuji; Y Nishino; S L You; K Y Yoo; J M Yuan; J Kim; S Tsugane; G Yang; R Wang; Y B Xiang; K Ozasa; M Nagai; M Kakizaki; C J Chen; S K Park; A Shin; H Ahsan; C X Qu; J E Lee; M Thornquist; B Rolland; Z Feng; W Zheng; J D Potter
Journal:  Ann Oncol       Date:  2011-12-06       Impact factor: 32.976

2.  Glutathione peroxidase tagSNPs: associations with rectal cancer but not with colon cancer.

Authors:  Ulrike Haug; Elizabeth M Poole; Liren Xiao; Karen Curtin; David Duggan; Li Hsu; Karen W Makar; Ulrike Peters; Richard J Kulmacz; John D Potter; Lisel Koepl; Bette J Caan; Martha L Slattery; Cornelia M Ulrich
Journal:  Genes Chromosomes Cancer       Date:  2012-02-27       Impact factor: 5.006

3.  Calcium, vitamin D, VDR genotypes, and epigenetic and genetic changes in rectal tumors.

Authors:  Martha L Slattery; Roger K Wolff; Jennifer S Herrick; Bette J Caan; Wade Samowitz
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

4.  Cancer: Subsite differences in colorectal cancer--anything new?

Authors:  John D Potter
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05       Impact factor: 46.802

5.  Body mass index and risk of colorectal carcinoma subtypes classified by tumor differentiation status.

Authors:  Akiko Hanyuda; Yin Cao; Tsuyoshi Hamada; Jonathan A Nowak; Zhi Rong Qian; Yohei Masugi; Annacarolina da Silva; Li Liu; Keisuke Kosumi; Thing Rinda Soong; Iny Jhun; Kana Wu; Xuehong Zhang; Mingyang Song; Jeffrey A Meyerhardt; Andrew T Chan; Charles S Fuchs; Edward L Giovannucci; Shuji Ogino; Reiko Nishihara
Journal:  Eur J Epidemiol       Date:  2017-05-16       Impact factor: 8.082

6.  Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia.

Authors:  Clare Abbenhardt; Elizabeth M Poole; Richard J Kulmacz; Liren Xiao; Karen Curtin; Rachel L Galbraith; David Duggan; Li Hsu; Karen W Makar; Bette J Caan; Lisel Koepl; Robert W Owen; Dominique Scherer; Christopher S Carlson; John D Potter; Martha L Slattery; Cornelia M Ulrich
Journal:  Int J Mol Epidemiol Genet       Date:  2013-09-12

7.  An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality.

Authors:  Martha L Slattery; Jennifer S Herrick; Lila E Mullany; Nicola Valeri; John Stevens; Bette J Caan; Wade Samowitz; Roger K Wolff
Journal:  Int J Cancer       Date:  2014-12-16       Impact factor: 7.396

8.  Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways.

Authors:  Martha L Slattery; Roger K Wolff; Karen Curtin; Frank Fitzpatrick; Jennifer Herrick; John D Potter; Bette J Caan; Wade S Samowitz
Journal:  Mutat Res       Date:  2008-10-15       Impact factor: 2.433

9.  Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site.

Authors:  Andrea N Burnett-Hartman; Michael N Passarelli; Scott V Adams; Melissa P Upton; Lee-Ching Zhu; John D Potter; Polly A Newcomb
Journal:  Am J Epidemiol       Date:  2013-03-03       Impact factor: 4.897

10.  Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer.

Authors:  Karen Curtin; Wade S Samowitz; Roger K Wolff; Cornelia M Ulrich; Bette J Caan; John D Potter; Martha L Slattery
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.